NRx Pharmaceuticals, Inc. (NRXP)

NASDAQ: NRXP · Real-Time Price · USD

3.730

+0.170 (4.78%)

At close: Jun 26, 2026, 4:00 PM EDT

3.810

+0.080 (2.14%)

After-hours: Jun 26, 2026, 7:59 PM EDT

NRx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.71	7.8	1.44	4.6	20.05	27.61
Cash & Short-Term Investments	6.71	7.8	1.44	4.6	20.05	27.61
Cash Growth	21.00%	440.33%	-68.60%	-77.09%	-27.35%	1385.33%
Accounts Receivable	0.18	0.16	-	-	-	-
Other Current Assets	0.47	0.93	1.86	2.29	5.74	5.11
Total Current Assets	7.36	8.89	3.3	6.88	25.8	32.71
Net Property, Plant & Equipment	1.2	0.7	0.01	-	-	-
Other Intangible Assets	0.88	0.93	-	-	-	-
Goodwill	1.79	1.79	-	-	-	-
Long-Term Investments	0.4	0.4	-	-	-	-
Other Long-Term Assets	0.28	0.25	0.34	0.43	0.02	0.02
Total Assets	11.9	12.96	3.65	7.32	25.82	32.73
Accounts Payable	4.4	4.27	4.13	4.63	2.08	3.69
Accrued Expenses	11.62	11.69	10.53	5.24	5.77	2.84
Short-Term Debt	-	-	-	-	-	0.52
Current Portion of Long-Term Debt	-	-	1.25	9.16	7.7	-
Current Portion of Leases	0.39	0.32	-	-	-	-
Other Current Liabilities	8.77	12.3	5.96	0.02	0.04	4.87
Total Current Liabilities	25.18	28.58	21.86	19.05	15.59	11.92
Long-Term Debt	-	-	5.01	-	2.82	-
Long-Term Leases	0.54	0.32	-	-	-	-
Total Long-Term Liabilities	0.54	0.32	5.01	-	2.82	-
Total Liabilities	25.72	28.89	26.87	19.05	18.41	11.92
Preferred Stock	-	-	-	0	-	-
Common Stock	0.03	0.03	0.02	0.01	0.07	0.06
Additional Paid-in Capital	294.48	290.93	255.04	241.41	230.34	203.99
Accumulated Other Comprehensive Income	-	-	-	-0	-	-
Retained Earnings	-308.33	-306.9	-278.27	-253.15	-223	-183.24
Shareholders' Equity	-13.82	-15.94	-23.22	-11.73	7.41	20.81
Total Liabilities & Equity	11.9	12.96	3.65	7.32	25.82	32.73
Total Debt	0.93	0.63	6.26	9.16	10.53	0.52
Net Cash (Debt)	5.78	7.17	-4.81	-4.57	9.53	27.09
Net Cash Growth	-19.36%	-	-	-	-64.82%	-
Net Cash Per Share	0.23	0.34	-0.45	-0.60	1.45	5.77
Book Value	-13.82	-15.94	-23.22	-11.73	7.41	20.81
Book Value Per Share	-0.54	-0.74	-2.18	-1.55	1.13	4.43
Tangible Book Value	-16.49	-18.66	-23.22	-11.73	7.41	20.81
Tangible Book Value Per Share	-0.65	-0.87	-2.18	-1.55	1.13	4.43

SEC Filings: 10-K · 10-Q